Stay updated with breaking news from Nasdaq Coep. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Coeptis Therapeutics (NASDAQ:COEP – Get Free Report) is one of 283 public companies in the “Biological products, except diagnostic” industry, but how does it compare to its peers? We will compare Coeptis Therapeutics to similar companies based on the strength of its analyst recommendations, institutional ownership, risk, profitability, dividends, earnings and valuation. Insider and Institutional […]
Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP – Get Free Report) was the target of a significant increase in short interest in March. As of March 31st, there was short interest totalling 107,700 shares, an increase of 171.3% from the March 15th total of 39,700 shares. Approximately 0.5% of the company’s stock are sold short. Based on […]
Coeptis Therapeutics (NASDAQ:COEP – Get Free Report) and Monte Rosa Therapeutics (NASDAQ:GLUE – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, valuation, institutional ownership, analyst recommendations, profitability, dividends and earnings. Profitability This table compares Coeptis Therapeutics […]
Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP – Get Free Report) CEO David Mehalick purchased 20,004 shares of the business’s stock in a transaction on Monday, January 8th. The shares were acquired at an average price of $0.66 per share, for a total transaction of $13,202.64. Following the completion of the purchase, the chief executive officer now […]
Coeptis Therapeutics (NASDAQ:COEP – Get Free Report) and Aligos Therapeutics (NASDAQ:ALGS – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, valuation, dividends, profitability, institutional ownership, earnings and analyst recommendations. Analyst Ratings This is a summary of […]